Orgler, Elisabeth http://orcid.org/0000-0003-1904-2553
Dabsch, Stefanie
Malfertheiner, Peter
Schulz, Christian
Funding for this research was provided by:
Ludwig-Maximilians-Universität München
Article History
Accepted: 28 December 2022
First Online: 2 March 2023
Declarations
:
: Dr. Orgler has a patent for a topical immunosuppressive agent for AIG licensed, which was sold to Marinomed Biotech AG. Dr. Orgler reports no other relevant financial activities outside the submitted work.Dr. Dabsch has a patent for a topical immunosuppressive agent for AIG licensed, which was sold to Marinomed Biotech AG. Dr. Dabsch reports no other relevant financial activities outside the submitted work.Dr. Malfertheiner reports personal fees from Aboca, personal fees from Bayer, personal fees from Biocodex, personal fees from Biohit, personal fees from Cinclus, personal fees from Imevax, personal fees from Malesci, personal fees from Menarini, and personal fees from Phatom, outside the submitted work.Dr. Schulz has nothing to disclose.